BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8661006)

  • 1. Structure of the human type IV collagen COL4A6 gene, which is mutated in Alport syndrome-associated leiomyomatosis.
    Zhang X; Zhou J; Reeders ST; Tryggvason K
    Genomics; 1996 May; 33(3):473-9. PubMed ID: 8661006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth.
    Thielen BK; Barker DF; Nelson RD; Zhou J; Kren SM; Segal Y
    Hum Mutat; 2003 Nov; 22(5):419. PubMed ID: 14517961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region.
    Heidet L; Cohen-Solal L; Boye E; Thorner P; Kemper MJ; David A; Larget Piet L; Zhou J; Flinter F; Zhang X; Gubler MC; Antignac C
    Cytogenet Cell Genet; 1997; 78(3-4):240-6. PubMed ID: 9465897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome.
    Ueki Y; Naito I; Oohashi T; Sugimoto M; Seki T; Yoshioka H; Sado Y; Sato H; Sawai T; Sasaki F; Matsuoka M; Fukuda S; Ninomiya Y
    Am J Hum Genet; 1998 Feb; 62(2):253-61. PubMed ID: 9463311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse leiomyomatosis associated with X-linked Alport syndrome: extracellular matrix study using immunohistochemistry and in situ hybridization.
    Heidet L; Cai Y; Sado Y; Ninomiya Y; Thorner P; Guicharnaud L; Boye E; Chauvet V; Solal LC; Beziau A; Torres RG; Antignac C; Gubler MC
    Lab Invest; 1997 Feb; 76(2):233-43. PubMed ID: 9042160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the 5'exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome.
    Sá MJ; Fieremans N; de Brouwer AP; Sousa R; e Costa FT; Brito MJ; Carvalho F; Rodrigues M; de Sousa FT; Felgueiras J; Neves F; Carvalho A; Ramos U; Vizcaíno JR; Alves S; Carvalho F; Froyen G; Oliveira JP
    J Med Genet; 2013 Nov; 50(11):745-53. PubMed ID: 23958657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis.
    Garcia-Torres R; Cruz D; Orozco L; Heidet L; Gubler MC
    Nephrologie; 2000; 21(1):9-12. PubMed ID: 10730274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours.
    Heidet L; Dahan K; Zhou J; Xu Z; Cochat P; Gould JD; Leppig KA; Proesmans W; Guyot C; Guillot M
    Hum Mol Genet; 1995 Jan; 4(1):99-108. PubMed ID: 7711741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis.
    Nozu K; Minamikawa S; Yamada S; Oka M; Yanagita M; Morisada N; Fujinaga S; Nagano C; Gotoh Y; Takahashi E; Morishita T; Yamamura T; Ninchoji T; Kaito H; Morioka I; Nakanishi K; Vorechovsky I; Iijima K
    J Hum Genet; 2017 Jul; 62(7):733-735. PubMed ID: 28275241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical spectrum of type IV collagen mutations.
    Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
    Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the 3' half of the human type IV collagen alpha 5 gene that is affected in the Alport syndrome.
    Zhou J; Hostikka SL; Chow LT; Tryggvason K
    Genomics; 1991 Jan; 9(1):1-9. PubMed ID: 2004755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of the alpha6(IV) chain of collagen type IV in Alport syndrome is related to a failure at the protein assembly level and does not result in diffuse leiomyomatosis.
    Zheng K; Harvey S; Sado Y; Naito I; Ninomiya Y; Jacobs R; Thorner PS
    Am J Pathol; 1999 Jun; 154(6):1883-91. PubMed ID: 10362815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of large deletions in X linked Alport syndrome using competitive multiplex fluorescence polymerase chain reaction].
    Wang F; Zhang YQ; Ding J; Yu LX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):760-767. PubMed ID: 29045953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine COL4A3 and COL4A4: sequencing, mapping and genomic organization.
    Wiersma AC; Millon LV; Hestand MS; Van Oost BA; Bannasch DL
    DNA Seq; 2005 Aug; 16(4):241-51. PubMed ID: 16147883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular diagnosis of Alport syndrome.
    Kashtan CE
    Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome.
    Renieri A; Galli L; Grillo A; Bruttini M; Neri T; Zanelli P; Rizzoni G; Massella L; Sessa A; Meroni M; Peratoner L; Riegler P; Scolari F; Mileti M; Giani M; Cossu M; Savi M; Ballabio A; De Marchi M
    Am J Med Genet; 1995 Nov; 59(3):380-5. PubMed ID: 8599366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization and expression of basement membrane collagen IV genes and their roles in human disorders.
    Sado Y; Kagawa M; Naito I; Ueki Y; Seki T; Momota R; Oohashi T; Ninomiya Y
    J Biochem; 1998 May; 123(5):767-76. PubMed ID: 9562604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion spanning the 5' ends of both the COL4A5 and COL4A6 genes in a patient with Alport's syndrome and leiomyomatosis.
    Renieri A; Bassi MT; Galli L; Zhou J; Giani M; De Marchi M; Ballabio A
    Hum Mutat; 1994; 4(3):195-8. PubMed ID: 7833948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal overgrowth of esophageal smooth muscle cells in diffuse leiomyomatosis-Alport syndrome caused by partial deletion in COL4A5 and COL4A6 genes.
    Oohashi T; Naito I; Ueki Y; Yamatsuji T; Permpoon R; Tanaka N; Naomoto Y; Ninomiya Y
    Matrix Biol; 2011 Jan; 30(1):3-8. PubMed ID: 20951201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.